251 related articles for article (PubMed ID: 32485391)
1. Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
Popescu CP; Fischer PR
Travel Med Infect Dis; 2020; 35():101764. PubMed ID: 32485391
[No Abstract] [Full Text] [Related]
2. Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
Pothen L; Yildiz H; De Greef J; Penaloza A; Beauloye C; Belkhir L; Yombi JC
Travel Med Infect Dis; 2020; 36():101788. PubMed ID: 32540396
[No Abstract] [Full Text] [Related]
3. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Lebeaux D; Revest M
Travel Med Infect Dis; 2020; 36():101819. PubMed ID: 32629139
[No Abstract] [Full Text] [Related]
4. Hydroxychloroquine and azithromycin as a treatment of COVID-19.
Fanin A; Calegari J; Beverina A; Tiraboschi S;
Intern Emerg Med; 2020 Aug; 15(5):841-843. PubMed ID: 32474851
[No Abstract] [Full Text] [Related]
5. Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Bonny A; Talle MA; Ngantcha M; Tayebjee MH
Travel Med Infect Dis; 2020; 37():101861. PubMed ID: 32889105
[No Abstract] [Full Text] [Related]
6. Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.
Hor CP; Hussin N; Nalliah S; Ooi WT; Tang XY; Zachariah S; Jugindar Singh GPS; Abdul Rani R; Perumal K; Cheah WK
J Infect; 2020 Aug; 81(2):e117-e119. PubMed ID: 32474031
[No Abstract] [Full Text] [Related]
7. Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Miller MC; Abraham GM; Obley AJ; Forciea MA; Jokela JA; Humphrey LL;
Ann Intern Med; 2020 Jul; 173(2):W48-W51. PubMed ID: 32551892
[No Abstract] [Full Text] [Related]
8. The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials.
Malviya A
Int J Infect Dis; 2020 Oct; 99():310-311. PubMed ID: 32738490
[No Abstract] [Full Text] [Related]
9. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Humphrey LL
Ann Intern Med; 2020 Sep; 173(5):W88-W89. PubMed ID: 32730105
[No Abstract] [Full Text] [Related]
10. Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
Mazzitelli M; Davoli C; Scaglione V; Fusco P; La Gamba V; Matera G; Trecarichi EM; Torti C
Travel Med Infect Dis; 2020; 37():101826. PubMed ID: 32739472
[No Abstract] [Full Text] [Related]
11. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
Frigerio M
Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
[No Abstract] [Full Text] [Related]
12. Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.
Parra-Lara LG; Martínez-Arboleda JJ; Rosso F
J Glob Antimicrob Resist; 2020 Sep; 22():680-684. PubMed ID: 32622008
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
Bonow RO; Hernandez AF; Turakhia M
JAMA Cardiol; 2020 Sep; 5(9):986-987. PubMed ID: 32936259
[No Abstract] [Full Text] [Related]
14. Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
Fleury V
Am J Epidemiol; 2020 Nov; 189(11):1227-1229. PubMed ID: 32685969
[TBL] [Abstract][Full Text] [Related]
15. RE: "EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS".
Peiffer-Smadja N; Costagliola D
Am J Epidemiol; 2020 Nov; 189(11):1443-1444. PubMed ID: 32685975
[No Abstract] [Full Text] [Related]
16. Review of: "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Gautret et al 2010, DOI:10.1016/j.ijantimicag.2020.105949.
Rosendaal FR
Int J Antimicrob Agents; 2020 Jul; 56(1):106063. PubMed ID: 32674928
[No Abstract] [Full Text] [Related]
17. An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19.
Intson K; Kumar S; Botta A; Neckles R; Leung C; Jawaid A
Swiss Med Wkly; 2020 Apr; 150():w20262. PubMed ID: 32347963
[No Abstract] [Full Text] [Related]
18. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
[No Abstract] [Full Text] [Related]
19. [Not Available].
Farfán-López M; Espinoza-Culupú A
Rev Peru Med Exp Salud Publica; 2020; 37(2):383-384. PubMed ID: 32876237
[No Abstract] [Full Text] [Related]
20. Problems with the analysis in "Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19".
Atkinson JG
Int J Infect Dis; 2020 Oct; 99():37. PubMed ID: 32738492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
